Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aripiprazole IM Depot Maintenance in Schizophrenia
NCT00705783Phase 3Completed
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization
- Start
- Jul 2008
- Primary completion
- Aug 2010
- Modality
- Small Molecules
- Countries
- 12
01
Overview
A Phase 3 trial of aripiprazole in schizophrenia, sponsored by Otsuka Pharmaceutical Development & Commercialization. Started Jul 2008; status: completed.
02
Drugs
aripiprazole
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT00705783.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00705783.